These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25827639)

  • 21. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
    J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.
    Neff KJ; Forde R; Gavin C; Byrne MM; Firth RG; Daly S; McAuliffe FM; Foley M; Coffey M; Coulter-Smith S; Kinsley BT
    Ir J Med Sci; 2014 Sep; 183(3):397-403. PubMed ID: 24142539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of continuous subcutaneous insulin infusion by a portable insulin pump during pregnancy in women with type 1 diabetes mellitus].
    Zorić S; Micić D; Kendereski A; Sumarac-Dumanović M; Cvijović G; Pejković D; Cvetković M; Ljubić A; Dukanac-Stamenković J
    Vojnosanit Pregl; 2006 Jul; 63(7):648-51. PubMed ID: 16875425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin Delivery Method and Admission for Glycemic Control in Pregnant Women with Type 1 Diabetes Mellitus.
    Sperling JD; Maggio L; Has P; Daley J; Coustan DR; Werner EF
    Am J Perinatol; 2018 Feb; 35(3):209-214. PubMed ID: 28709165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005542. PubMed ID: 17636806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin for the Management of Type 1 Diabetes Mellitus in Pregnancy: Association with Neonatal Chemical Hypoglycemia.
    Sargent JA; Roeder HA; Ward KK; Moore TR; Ramos GA
    Am J Perinatol; 2015 Dec; 32(14):1324-30. PubMed ID: 26461928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.
    Volpe L; Pancani F; Aragona M; Lencioni C; Battini L; Ghio A; Resi V; Bertolotto A; Del Prato S; Di Cianni G
    Gynecol Endocrinol; 2010 Mar; 26(3):193-6. PubMed ID: 19728190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
    Lepore G; Bruttomesso D; Bonomo M; Dodesini AR; Costa S; Meneghini E; Corsi A; Nosari I; Trevisan R
    Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions.
    Chen R; Ben-Haroush A; Weismann-Brenner A; Melamed N; Hod M; Yogev Y
    Am J Obstet Gynecol; 2007 Oct; 197(4):404.e1-5. PubMed ID: 17904979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of continuous subcutaneous insulin infusion on quality of life.
    Lukács A; Kiss-Tóth E; Varga B; Soós A; Takác P; Barkai L
    Int J Technol Assess Health Care; 2013 Jan; 29(1):48-52. PubMed ID: 23270655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous subcutaneous insulin infusion].
    Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
    Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.